Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

MTEM

Molecular Templates (MTEM)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MTEM
DataOraFonteTitoloSimboloCompagnia
12/02/202521:53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MTEMMolecular Templates Inc
02/01/202522:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
19/12/202422:10GlobeNewswire Inc.Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing RulesNASDAQ:MTEMMolecular Templates Inc
04/12/202422:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
02/12/202423:06GlobeNewswire Inc.Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price RequirementsNASDAQ:MTEMMolecular Templates Inc
15/11/202412:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:MTEMMolecular Templates Inc
12/11/202415:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MTEMMolecular Templates Inc
28/10/202422:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MTEMMolecular Templates Inc
17/10/202423:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MTEMMolecular Templates Inc
30/09/202423:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
14/08/202422:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
14/08/202422:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
13/08/202422:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
03/06/202414:11GlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
15/05/202423:11GlobeNewswire Inc.Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
09/04/202414:11GlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
29/03/202413:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
28/03/202413:11GlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
15/02/202402:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
14/02/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
08/02/202423:55GlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
13/11/202322:11GlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/11/202321:11GlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
01/11/202321:12GlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
06/10/202323:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
28/09/202322:11GlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
21/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTEMMolecular Templates Inc
11/08/202317:22GlobeNewswire Inc.Molecular Templates Announces 1-for-15 Reverse Stock SplitNASDAQ:MTEMMolecular Templates Inc
10/08/202315:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MTEMMolecular Templates Inc
10/08/202314:08GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MTEM

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network